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ABC of arterial and venous disease
Secondary prevention of transient ischaemic attack and stroke
Kennedy R Lees, Philip M W Bath, A Ross Naylor
Stroke or transient ischaemic attack is common and likely to be
fatal or cause serious disability. A second stroke will not
necessarily be of the same type as the initial event, although
haemorrhages tend to recur. Patients with previous stroke
commonly succumb to other vascular events, in particular
myocardial infarction. Effective secondary prevention depends
on giving attention to all modifiable risk factors for stroke as
well as treating the causes of the initial stroke. Four questions
should be answered:
Is it acute cerebrovascular disease?
The key features of acute cerebrovascular disease are focal
neurological deficit, sudden onset, and absence of an alternative
explanation. Abrupt onset of a dense hemiparesis before
gradual improvement in a conscious patient rarely causes
doubt, but conditions which commonly mimic stroke must be
considered (see previous article BMJ 2000;320:920›3).
Is it ischaemic or haemorrhagic
stroke?
Neither clinical history nor examination can reliably distinguish
infarction from primary intracerebral haemorrhage. A small
bleed can produce transient symptoms, although these rarely
resolve within an hour.
Cerebral imaging is essential, and the choice and timing of
the scan is important. Haemorrhage is immediately apparent
on computed tomography, but its distinctive appearance
becomes indistinguishable from infarction over a few weeks; for
major symptoms, a computed tomogram taken within two
weeks should still be diagnostic, but a small bleed may be
missed after one week.
Magnetic resonance imaging has a greater sensitivity for
brain stem, cerebellar, and small ischaemic strokes of the brain
than computed tomography. It can also identify haemorrhagic
stroke and remains diagnostic long after signs have become
undetectable on computed tomography.
Risk of recurrence after stroke or transient
ischaemic attack
Stroke
x 8% a year
Transient ischaemic attack
x 8% risk of stroke in first month
x 5% risk of stroke a year thereafter
x 5% risk of myocardial infarction a year
Modifiable risk factors for stroke
x Hypertension
x Smoking
x Diabetes mellitus
x Diet: high salt and fats, low potassium and vitamins
x Excess alcohol intake
x Morbid obesity
x Low physical exercise
x Low temperature
x Cholesterol concentration—at least in patients with coronary disease
Correct imaging techniques for patients with symptoms of
stroke
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Computed tomograms on days 0 (left) and 8 (right) after left subcortical
haemorrhage presenting as a transient ischaemic attack with symptoms
lasting 50 minutes. Note the resolution of diagnostic appearances at day 8
Magnetic resonance image of posterior
fossa of brain in patient with right
cerebellar infarction
T1 weighted magnetic resonance
image of left subcortical
haemorrhage (day 9 in same
patient as computed tomograms
above)
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Cardioembolic or vascular aetiology?
Up to a quarter of ischaemic strokes are due to embolism from
the heart or major vessels. In these patients, full anticoagulation
should be considered. Embolic stroke can affect any vascular
territory but can rarely be diagnosed conclusively. Certain
features should prompt a search for an embolic source.
Transthoracic echocardiography is usually adequate, but
transoesophageal echocardiography is justified if the results are
equivocal or the index of suspicion is high.
Anterior or posterior circulation?
The vertebrobasilar arteries supply the brain stem, cerebellum,
and occipital lobes; the cerebral hemispheres are supplied
through the carotid arteries. This distinction is important since
carotid Doppler ultrasonography with a view to endarterectomy
is justified in patients with severe carotid disease only if
symptoms have arisen from the anterior circulation.
Hospital referral
Although the approach to investigation of stroke is simple, few
general practitioners will have open access to the necessary
facilities or see sufficient cases to develop expertise in
interpretation of the results. Patients with suspected stroke need
urgent telephone or fax referral to a “fast track” specialist
cerebrovascular clinic or stroke unit because of the time
limitations on the diagnostic capability of computed tomography
and the limited availability of magnetic resonance imaging.
Management of risk factors
Smoking is an important correctable risk factor and should be
strongly discouraged. The risk of stroke of a smoker returns to
that of a non›smoker within three to five years of stopping
smoking.
Immediate reduction of blood pressure may be deleterious,
but long term risk is inversely related to the blood pressure
achieved. Treatment may therefore be justified even in patients
with “normal” blood pressures. Hypertension should be treated
one to two weeks after a stroke on the basis of British
Hypertension Society guidelines. Patients at high risk of a
further stroke (such as elderly people) derive the greatest
benefit from treatment.
The role of serum cholesterol concentration in the
pathogenesis of stroke remains debatable. Nevertheless, statins
have been shown to reduce the risk of stroke in clinical trials of
patients with coronary heart disease. Lowering cholesterol
concentrations with a statin after atherosclerotic stroke or
transient ischaemic attack probably reduces recurrent events
and the risk of developing ischaemic heart disease. Since stroke
patients represent such a high risk population, the cost of
treatment may be justified.
Diabetes confers a substantial disadvantage for survival and
functional outcome on patients with acute stroke. The
mechanism for this is unknown, but since it is a long term effect,
attempts should be made to normalise blood glucose
concentrations. Blood pressure targets are lower for diabetic
than non›diabetic patients.
Raised plasma homocysteine concentration is increasingly
linked to premature vascular disease and can be easily lowered
through vitamin supplements (folate and pyridoxine). Although
the value of lowering homocysteine concentrations has not
been proved, younger patients with raised plasma homocysteine
concentrations may benefit.
Embolic causes of stroke found on echocardiography
x Mitral stenosis
x Left atrial enlargement ( > 4 cm)
x Dyskinetic or akinetic left ventricle
x Severe global left ventricular dysfunction
x Valvular vegetation
x Left atrial or ventricular thrombus
x Mitral valve calcification
x Calcific aortic valves or stenosis predispose to embolism but may
not justify anticoagulation
Justifications for echocardiography
x Atrial fibrillation
x Heart failure
x Myocardial infarction within
3 months
x Electrocardiographic
abnormalities:
Myocardial infarction or
ischaemia
Bundle branch block
x Cardiac murmur
x Peripheral embolism
x Clinical events in >2 territories:
Right and left hemisphere
Anterior and posterior
circulation
x >2 cortical events (even in
same territory) unless severe
ipsilateral carotid disease
Blood pressure targets (mm Hg) in non›diabetic and diabetic
stroke patients
No diabetes Diabetes
Titrate to diastolic blood pressure <85 <80
Optimal blood pressure < 140/85 < 130/80
Suboptimal blood pressure >150/90 >140/85
Carotid Doppler ultrasonogram in patient with severe internal carotid artery
stenosis. Upper panel shows angle of insonation (a) of internal carotid artery
and sampling window (b); the velocity of systolic blood flow at the point of
maximal narrowing (c), is nearly 4 m/s (normal <1 m/s). Stenosis causes flow
velocity to increase and produces turbulence, which is seen as shading
within the Doppler spectrum (d)
‡  200/110
Days or
weeks Months Months
140-199/90-109 130-139/80-89
‡  140/90 130-139/80-89
< 130/80
Treat Treat Reassess
annually
Reassess
in 5 years
Blood pressure thresholds (mm Hg) for treatment after stroke or transient
ischaemic attack (based on British Hypertension Society Guidelines 1999)
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Antiplatelet therapy and
anticoagulation
Patients with atrial fibrillation should receive warfarin if they
have no contraindications, aiming at an international
normalised ratio of 2.0›3.0. Patients with other important
sources of cardiac embolism also benefit from warfarin. Only
patients with mechanical prosthetic heart valves require a
higher international normalised ratio target of 2.5›4.5, although
the exact value depends on the type of valve.
For all other patients with ischaemic stroke, antiplatelet
therapy would be first line treatment. Aspirin is inexpensive and
simple to administer, and its benefits are conclusively proved.
An initial dose of 300 mg followed by 75 mg daily is advised
(higher doses have little advantage but increase gastrointestinal
side effects and bleeding).
Modified release dipyridamole (200 mg twice daily) has an
independent and additive effect to low dose aspirin in
preventing further strokes but not coronary events or overall
mortality. The routine addition of dipyridamole to aspirin for
secondary prevention of strokes may be cost effective.
Clopidogrel (75 mg daily), a new antiplatelet drug, is well
tolerated and was slightly more effective than aspirin in a large
trial. However, it is not cost effective for initial treatment.
Clopidogrel should be used in patients with true intolerance to
aspirin (allergy or intractable side effects on low dose enteric
coated aspirin with or without antiulcer drugs); dipyridamole
alone does not prevent cardiac events.
Carotid surgery and angioplasty
Firm evidence from two large trials has clarified the role of
carotid endarterectomy in patients with ipsilateral severe carotid
stenosis. Patients with severe disease benefit from surgery for up
to 12 months after the most recent cerebral event. The benefit
derived is inextricably linked to the operative risk (stroke or
death within 30 days). In the randomised trials, the operative
mortality in patients with severe disease was 1.0%, the risk of
death or disabling stroke < 4%, and the risk of death or any
stroke < 7.5%. Surgical risk is inversely proportional to surgical
volume, implying that patients should be referred to busy
carotid endarterectomy centres. Surgeons must quote their own
risks rather than results obtained in trials.
Any patient presenting with carotid territory symptoms
should be considered a potential candidate for carotid
endarterectomy, and carotid Doppler ultrasonography should
be done if the patient is fit for surgery. The presence or absence
of a carotid bruit is irrelevant. An ongoing meta›analysis may
further refine the indications, particularly regarding the
management of women and patients with isolated retinal
symptoms, who seem to have a lower overall risk of stroke.
A successful carotid endarterectomy is not a major
procedure, and most patients can be discharged home the day
after surgery. Neither clinical nor ultrasonographic surveillance
Main contraindications to long term
warfarin treatment
x Gastrointestinal bleeding
x Active peptic ulceration
x Frequent falls
x Alcohol misuse
x History of intracranial haemorrhage
Age, by itself, is not a contraindication
Summary of results from European carotid surgery trial
Stenosis
(%)
Incidence of stroke (%) Absolute risk
reduction (%)
Relative risk
reduction
(%)Surgery
arm
Medical
arm
0›30 11.8 6.2 − 5.6 at 3 years None
31›69 16.0 15.0 − 1.0 at 5 years None
70›99 12.3 21.9 9.6 at 3 years 44 at 3 years
Computed tomography
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Aspirin intolerance
or contraindication
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Aspirin
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1-2 weeks
Acute
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of further
vascular
events
Aspirin intolerance
or contraindication
Dipyridamole intolerance
or contraindication
Continue long
term unless
contraindication
develops
Aspirin 75-300 mg and
Dipyridamole 200 mg
twice daily
Secondary
prevention
of stroke
and other
vascular
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Risk of stroke in patients not having surgery according to degree of stenosis.
Data from European Carotid Surgery Trialists’ Collaborative Group, Lancet
1998;351:1379›87
Indications for carotid endarterectomy
Surgery not indicated
x Carotid territory symptoms and an ipsilateral 0›69% stenosis
x Complete occlusion of the carotid artery
Surgery indicated
x Carotid territory symptoms within 6 months and an ipsilateral
70›99% stenosis
x Carotid territory symptoms within 12 months and an ipsilateral
80›99% stenosis
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prevents late stroke, and so most patients are discharged from
follow up at six weeks with the proviso that they should be
referred immediately should further cerebral ischaemic
events occur.
In carotid angioplasty the stenosis is dilated by using a
balloon catheter introduced percutaneously through the
femoral artery. The potential advantages of carotid angioplasty
include reduced hospital stay, cranial nerve injury, wound
complications, and other cardiovascular morbidity. The main
concern about carotid angioplasty is the risk of embolic stroke
at the time of the procedure and recurrent stenosis. Carotid
angioplasty aids the management of fibromuscular dysplasia,
radiation injury, and symptomatic restenosis after carotid
endarterectomy. Otherwise, carotid angioplasty should not
be performed outside randomised trials and, as with carotid
endarterectomy, outcomes in individual centres should
be audited.
Complex cases
Secondary prevention of stroke is rightly the province of
general practitioners and the preceding suggestions will cover
most patients with recent stroke. However, patients with
complex conditions will need access to specialist services,
although definitive trial evidence justifying therapeutic
decisions in such cases is often absent. Patients should be
monitored for compliance with treatment and the development
of complications such as renovascular disease, ischaemic heart
disease, and further cerebrovascular problems. Optimal dietary,
smoking, lipid, and blood pressure management is always
required in addition to antithrombotic treatment.
G T McInnes and L Ramsay contributed towards the blood pressure guidelines.
M R Walters supplied some of the pictures and J Overell supplied the antiplatelet
flow chart.
Kennedy R Lees is professor of cerebrovascular medicine, university
department of medicine and therapeutics, Western Infirmary,
Glasgow (k.r.lees@clinmed.gla.ac.uk); Philip M W Bath is professor of
stroke medicine, University Hospital, Nottingham; and A Ross Naylor
is senior lecturer, department of surgery, Leicester Royal Infirmary,
Leicester.
Complex cases that may require hospital referral
Case Possible treatment
Recurrent stroke or transient
ischaemic attack despite antiplatelet
treatment (treatment failure)
Consider higher doses of
aspirin, addition of
dipyridamole (if not already
prescribed), substitution or
addition of clopidogrel, or
substitution or addition of
warfarin
Recurrent embolic events despite
adequate anticoagulation with
warfarin
Consider adding low dose
aspirin
Recurrent non›haemodynamic
symptoms from inoperable severe
carotid stenosis or serious
intracranial stenosis despite
antiplatelet treatment
Consider warfarin
Hypertension and inoperable severe
carotid stenosis
Consider cerebral blood flow
monitoring (with
ultrasonography or
radionucleotide perfusion
scanning) before
antihypertensive treatment
The ABC of arterial and venous disease is edited by Richard Donnelly,
professor of vascular medicine, University of Nottingham and
Southern Derbyshire Acute Hospitals NHS Trust (richard.donnelly@
nottingham.ac.uk) and Nick J M London, professor of surgery,
University of Leicester, Leicester (sms16@leicester.ac.uk). It will be
published as a book later this year.
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Severe carotid stenosis before (left) and after carotid angioplasty and
stenting (right)
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